Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)

Clinical trial NCT03853993 · COMPLETED

Trial details

NCT number: NCT03853993
Sponsor: Sinovac Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Seasonal Influenza

Start date: 2018-01-23
Primary completion: 2018-08-17
Enrollment: 2380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.